Investigational Drug Details
| Drug ID: | D461 |
| Drug Name: | ALG-055009 |
| Synonyms: | ALG055009 |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | Thyroid hormone receptor beta agonist |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 1 on-going (NCT05090111) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0349 | NCT05090111 | Phase 1 | Recruiting | No Results Available | December 1, 2021 | January 11, 2022 | Details |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|